With this acquisition, Grupo Palex inaugurates a new business unit that will cover all areas of oncology and all of its phases and the protection of healthcare professionals in this branch.

Both Marisa Ogando, director of Bioterra, and Xavier Carbonell, CEO of Palex Group, are optimistic and excited about the future ahead for both companies because of this operation.